Mitigate Human Error And Improve Performance In Pharma QC

By Peter McMichael, Head of Quality Control, and Ross Adamson, Analytical Investigator, Almac Group

Recent reports highlighting the rising cost of the drug development process are likely little surprise to pharmaceutical companies that have been watching these numbers rising year after year, which is why maximizing efficiency has become a primary focus in drug development and manufacture. Yet, there are still many elements that rely on human observation, and with the pressure to improve efficiency sometimes interpreted as a need to simply move faster, there is an increased risk for costly mistakes that could threaten patient safety.

Recognizing the need to manage and mitigate analyst error throughout GMP manufacture and process life cycles, the Quality Control team at Almac Sciences, part of the Almac Group, took a closer look at its internal procedures and have developed processes and strategies to help ensure ongoing high Quality of safe and effective products. Download the full article to find out what the team learned during these efforts and what changes were implemented to drive a culture of quality across its organization.